当前位置:首页 - 行情中心 - 佐力药业(300181) - 财务分析 - 现金流量表

佐力药业

(300181)

  

流通市值:104.85亿  总市值:121.97亿
流通股本:6.03亿   总股本:7.01亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,139,564,083.671,495,325,281.98518,467,304.82,609,045,414.96
  收到的税费返还58,883,400.3137,770,840.3113,958,992.73-
  收到其他与经营活动有关的现金19,295,819.9316,341,929.4611,478,330.19128,139,406.06
  经营活动现金流入小计2,217,743,303.911,549,438,051.75543,904,627.722,737,184,821.02
  购买商品、接受劳务支付的现金682,246,126.71423,941,855.54203,794,016.881,002,036,656.42
  支付给职工以及为职工支付的现金252,698,606.02177,779,413.92105,987,064.09310,573,917.6
  支付的各项税费251,242,645.53175,890,393.3276,928,042.09284,423,585.45
  支付其他与经营活动有关的现金765,554,483.93482,242,376.94234,633,884.67843,103,421.15
  经营活动现金流出小计1,951,741,862.191,259,854,039.72621,343,007.732,440,137,580.62
  经营活动产生的现金流量净额266,001,441.72289,584,012.03-77,438,380.01297,047,240.4
二、投资活动产生的现金流量:
  收回投资收到的现金---151,000,000
  取得投资收益收到的现金3,585,0003,585,000-638,792.83
  处置固定资产、无形资产和其他长期资产收回的现金净额56,600--998,945.89
  处置子公司及其他营业单位收到的现金净额2,431,9982,431,998--
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计6,073,5986,016,998-152,637,738.72
  购建固定资产、无形资产和其他长期资产支付的现金213,470,483.25149,921,435.32129,980,161.09262,888,474
  投资支付的现金20,000,00020,000,000--
  取得子公司及其他营业单位支付的现金2,431,9982,431,998--
  支付其他与投资活动有关的现金56,772.55---
  投资活动现金流出小计235,959,253.8172,353,433.32129,980,161.09262,888,474
  投资活动产生的现金流量净额-229,885,655.8-166,336,435.32-129,980,161.09-110,250,735.28
三、筹资活动产生的现金流量:
  取得借款收到的现金681,100,000494,300,000176,000,000529,159,125
  收到其他与筹资活动有关的现金52,014,25046,000,75055,900,7502,217,500
  筹资活动现金流入小计733,114,250540,300,750231,900,750531,376,625
  偿还债务支付的现金447,400,000280,400,00081,000,000324,368,738.22
  分配股利、利润或偿付利息支付的现金424,770,686.16433,705,331.949,354,626.33327,840,645.25
  其中:子公司支付给少数股东的股利、利润7,600,0007,600,000-7,044,239.19
  支付其他与筹资活动有关的现金4,024,115.132,090,531.931,462,820.22218,553,248.75
  筹资活动现金流出小计876,194,801.29716,195,863.8791,817,446.55870,762,632.22
  筹资活动产生的现金流量净额-143,080,551.29-175,895,113.87140,083,303.45-339,386,007.22
四、汇率变动对现金及现金等价物的影响-96.54-103.54-25.55162.35
五、现金及现金等价物净增加额-106,964,861.91-52,647,640.7-67,335,263.2-152,589,339.75
  加:期初现金及现金等价物余额775,555,053.14775,555,053.14802,775,760.19928,144,392.89
  期末现金及现金等价物余额668,590,191.23722,907,412.44735,440,496.99775,555,053.14
补充资料:
  净利润-379,193,091.62-515,958,086.72
  资产减值准备-11,119,072.67-18,765,302.7
  固定资产和投资性房地产折旧-34,039,687.05-63,824,641.63
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,039,687.05-63,824,641.63
  无形资产摊销-2,432,122.85-4,419,593.27
  长期待摊费用摊销-2,308,647.08-3,674,277.27
  处置固定资产、无形资产和其他长期资产的损失-0--352,220.71
  固定资产报废损失-23,166.08-8,061,566.73
  财务费用-6,664,453.44-9,289,022.48
  投资损失-1,339,602.32-662,074.01
  递延所得税--1,465,508.49--4,277,244.3
  其中:递延所得税资产减少--1,097,299.31--4,902,403.45
    递延所得税负债增加--368,209.18-625,159.15
  存货的减少-42,857,480.84--108,509,822.5
  经营性应收项目的减少--241,000,415.16--307,219,747.45
  经营性应付项目的增加-50,001,624.1-89,232,151.16
  现金的期末余额-722,907,412.44-775,555,053.14
  减:现金的期初余额-775,555,053.14-928,144,392.89
  现金及现金等价物的净增加额--52,647,640.7--152,589,339.75
公告日期2025-10-282025-08-202025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑